Filing Details
- Accession Number:
- 0000897101-11-002031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-30 16:31:09
- Reporting Period:
- 2011-11-28
- Filing Date:
- 2011-11-30
- Accepted Time:
- 2011-11-30 16:31:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
788920 | Pro Dex Inc | PDEX | Surgical & Medical Instruments & Apparatus (3841) | 841261240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1478067 | John Nicholas Swenson | 3033 Excelsior Boulevard Suite 560 Minneapolis MN 55416 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-11-28 | 41,700 | $2.32 | 386,883 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-11-29 | 4,587 | $2.36 | 391,470 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.30 to $2.33, inclusive, on November 28, 2011. The reporting person undertakes to provide to Pro-Dex, Inc., any security holder of Pro-Dex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.38, inclusive, on November 29, 2011. The reporting person undertakes to provide to Pro-Dex, Inc., any security holder of Pro-Dex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.